ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,258.61
0.00%
Dow Jones
44,860.31
0.28%
Gold vs US Dollar
2,647.155
0.57%
Brent Oil
72.465
0.02%
Bitcoin
93,416.34
1.56%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Synta Pharmaceuticals Corp. (MM) (SNTA)

  7. Synta Pharmaceuticals Corp. (MM) (SNTA) News

Synta Pharmaceuticals Corp. (MM) (SNTA)

Synta Pharmaceuticals Corp. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNTA
DateTimeSourceHeadlineSymbolCompany
29/07/201619:13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
29/07/201617:25Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
26/07/201621:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
26/07/201621:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
26/07/201621:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
26/07/201621:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
26/07/201621:20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
26/07/201621:19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
26/07/201621:19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
26/07/201621:17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
26/07/201619:38Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
22/07/201621:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
22/07/201621:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
22/07/201621:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
22/07/201621:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
22/07/201615:30GlobeNewswire Inc.Madrigal Pharmaceuticals Completes Merger with Synta to Create Leading Cardiovascular-Metabolic Diseases and NASH CompanyNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
21/07/201620:17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
20/07/201620:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
06/07/201620:28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
01/07/201611:35PR Newswire (US)Why Investors Have These Biotech Stocks on Their Radar? - Synta Pharma, Idera Pharma, Threshold Pharma, and Viking Therapeuti...NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
14/06/201612:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
08/06/201620:30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
08/06/201620:28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
08/06/201620:15Business WireSynta Announces Date and Location of Annual Meeting of Stockholders to Vote on Merger with Madrigal PharmaceuticalsNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
08/06/201620:03Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
03/06/201621:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
02/06/201620:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
02/06/201620:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
02/06/201611:00Business WireSynta Pharmaceuticals to Present at Upcoming Investor Conferences in JuneNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
27/05/201612:20PR Newswire (US)Why Biotech Stocks Fascinate Investors? - Synta Pharma, CTI BioPharma, Lpath, and Heat BiologicsNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
 Showing the most relevant articles for your search:NASDAQ:SNTA

Your Recent History

LSE
EZJ
Easyjet
LSE
SCLP
Scancell
LSE
VAST
Vast Resources
LSE
AAZ
Anglo Asian Mining
LSE
BARC
Barclays
LSE
FRG
Firering Strategic Miner...
LSE
TERN
Tern
LSE
KEFI
Kefi Gold And Copper
LSE
GDR
Genedrive
LSE
ENT
Entain
LSE
EDEN
Eden Research
LSE
ORCP
Oracle Power
LSE
ZED
Zenova
LSE
MIN
Minoan
LSE
TRT
Transense Technologies
LSE
POS
Plexus
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Gold Trader

    1 year 35%, 2 years 45% and *3 years 60%

    *Across 3 years £3655.44 only £1462.17